Advertisement
Asia
Subscribe to Asia

The Lead

Report: Single-Use Bioreactors Market to Grow to $471M by 2019

January 28, 2015 8:02 am | News | Comments

The single use bioreactors (SUBs) market is expected to grow at a double digit CAGR of 18.4% to reach $470.9 million by 2019 from $202.5 million in 2014. Developing markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations.

EMA Recommends Suspending GVK Biosciences Medicines over Flawed Studies

January 23, 2015 8:06 am | News | Comments

A number of medicines for which authorization in the European Union (EU) was primarily based on...

Catalent Biologics and MGC Pharma Announce Partnership for Biomanufacturing in Asia

January 19, 2015 12:29 pm | News | Comments

Catalent Pharma Solutions and Mitsubishi Gas Chemical Company, Inc. (MGC), have entered into a...

Roche, Meiji and Fedora to Collaborate on New Antibiotic to Fight Increasing Bacterial Resistance

January 13, 2015 11:26 am | News | Comments

Roche, Meiji Seika Pharma and Fedora have entered into a license agreement for the development...

View Sample

FREE Email Newsletter

Health Canada Quarantines Products From Two Indian Companies

December 24, 2014 11:00 am | News | Comments

This action comes in light of recent information from a trusted regulatory partner that raises concerns about the reliability of the laboratory data generated at these sites. Health Canada is taking this action as an interim precautionary measure to help mitigate any potential risk.

PPD and SNBL to Provide Clinical Development Services in Japan

December 24, 2014 8:25 am | News | Comments

Pharmaceutical Product Development and Shin Nippon Biomedical Labs have formed a joint venture that will provide a full range of clinical development services in Japan, including Phase I-IV clinical trial monitoring, project management, site intelligence and activation, biostatistics, data management, medical writing, pharmacovigilance, regulatory and FSP services.

Sartorius Selling Industrial Technologies Division to Minebea Co.

December 22, 2014 8:36 am | News | Comments

Sartorius, an international laboratory and pharmaceutical equipment provider, is selling its Industrial Technologies Division (Intec) to the Japanese Minebea Co., Ltd. (Minebea) and their partner, the Development Bank of Japan Inc.   

Advertisement

Charges Dropped Against Two Former Lilly Scientists

December 8, 2014 8:34 am | News | Comments

Two former Eli Lilly and Co. employees who were accused of sending trade secrets worth more than $55 million to a competing Chinese drug company will no longer face charges, the U.S. attorney's office announced Friday.      

GlobalData: Age-Related Macular Degeneration Treatment Market Value to Exceed $10B by 2023

December 4, 2014 9:51 am | News | Comments

The Age-related Macular Degeneration treatment market across seven major countries (the US, UK, Germany, France, Spain, Italy and Japan) will almost double in value from $5.1 billion in 2013 to $10.1 billion by 2023, according to research and consulting firm GlobalData.

Otsuka to Buy Avanir for $3.5B

December 2, 2014 7:08 am | by By The Associated Press | News | Comments

Otsuka Pharmaceutical will spend $3.5 billion in cash to buy Avanir Pharmaceuticals in a deal that expands the Japanese drugmaker's portfolio of neurologic disease treatments. Avanir shareholders will receive $17 per share, according to the agreement announced Tuesday.

Vetter Opens Singapore Office to Support Growing Asian Healthcare Market

November 20, 2014 8:42 am | News | Comments

Vetter has announced the opening of a new representative office in Singapore. The announcement was made at a ceremony attended by members of local government agencies and a number of executives of pharmaceutical/biotech companies with a presence in the Asian region, as well as Vetter executives.

China Convicts Pharmaceutical Web Marketer in Anti-Rumor Campaign

November 18, 2014 8:06 am | News | Comments

A Beijing court has convicted an Internet marketer of illegal business practices and sentenced him to four years in prison for posting false information and deleting posts critical of his clients, in a case that state media have used to praise a government crackdown on online expression.

Advertisement

Drug Maker Arrested in India Sterilization Deaths

November 17, 2014 8:25 am | by MUNEEZA NAQVI, Associated Press | News | Comments

Press Trust of India reported that Ramesh Mahawar of Mahawar Pharma Pvt Ltd and his son were arrested and charged with fraud. Police Superintendent O.P. Pal told PTI that the men were arrested on the complaint of food and drug administration officials.

India Doctor Arrested, Denies Role in Women Deaths, Blames Medication

November 13, 2014 10:07 am | by MUNEEZA NAQVI, Associated Press | News | Comments

The doctor who conducted sterilization procedures after which 13 women died in central India was arrested, but insisted he didn't do anything wrong — even though he said he used to perform up to 10 times more surgeries a day than allowed.    

Doctors Rush to India after Sterilization Deaths

November 12, 2014 8:30 am | by KATY DAIGLE, Associated Press | News | Comments

A team of doctors rushed to central India on Wednesday after at least 12 women died and dozens of others fell ill following sterilization surgeries in a free, nationwide program aimed at limiting births in the world's second-most populous nation, officials said.

China Factory Whirs Overtime to Make Ebola Suits

November 6, 2014 10:56 am | by ZHANG WEIQUN, Associated Press | News | Comments

Far from the Ebola hot zone, the sewing and gluing machines at a factory in China have been whirring more than usual to produce crucial yellow suits that protect the front-line medics more than 11,000 kilometers (7,000 miles) away in West Africa.

Beijing Wants APEC to Push Chinese Trade Pact

November 6, 2014 8:19 am | by JOE McDONALD, AP Business Writer | News | Comments

China plans to use a meeting of Asia-Pacific leaders to promote a regional trade initiative at a time when progress on a rival U.S.-led trade deal has stalled, injecting a note of rivalry into an annual summit that aims for consensus.   

Advertisement

GVK BIO to Acquire Vanta Bioscience

November 6, 2014 8:16 am | News | Comments

GVK BIO has announced the signing of a definitive agreement to acquire Vanta Bioscience, a full service preclinical GLP toxicology and safety assessment contract research organization operating out of Chennai, India.      

Ex-Union Carbide Chief Anderson Dies at 92

November 2, 2014 6:29 pm | by CURT ANDERSON, Associated Press | News | Comments

Warren M. Anderson, who headed Union Carbide Corp. when a chemical leak killed thousands of people in Bhopal, India, in 1984, has died in Florida at 92. Anderson's death was not announced by his family but was confirmed Friday by The Associated Press through public records.

New Bill in Japan Would Extend Sales Suspension of Quasi-Legal Drugs

November 2, 2014 5:28 pm | News | Comments

The ruling Liberal Democratic Party and its coalition partner have drawn up a draft amendment to the pharmaceutical affairs law that would extend the suspension of sales of quasi-legal drugs nationwide when a retailer is ordered to suspend sales of such drugs.

Chinese Pharma Firm to Establish Operations in Virginia

October 30, 2014 12:56 pm | News | Comments

Virginia's Gov. Terry McAuliffe said Thursday that UniTao Pharmaceuticals LLC has purchased the Boehringer Ingelheim plant that's slated to close by the end of the year.              

Catalent Appoints New Asia Pacific President

October 28, 2014 9:10 am | News | Comments

Catalent today announced the promotion of Australia Country General Manager, Mark Bisset, to President, Catalent Asia Pacific. He succeeds David Heyens who has announced that he plans to retire from Catalent on December 31st 2014.    

Fujifilm to Buy U.S. Vaccine Maker to Expand Biopharma Business

October 27, 2014 8:56 am | News | Comments

Fujifilm will acquire U.S. vaccine maker Kalon Biotherapeutics to expand its biopharmaceutical business, with the Japanese firm having gained prominence for offering a possible treatment for Ebola patients.        

China Gives $6M for Food in Ebola Countries

October 20, 2014 8:24 am | News | Comments

China has donated $6 million to help stave off food shortages in the three African countries worst affected by the Ebola virus, the World Food Program announced Monday, part of Beijing's growing assistance to a continent where its companies have become major investors.

Overseas Deal Rules End One Combo, Alter Another

October 3, 2014 1:46 pm | by Tom Murphy - AP Business Writer - Associated Press | News | Comments

New government rules aimed at curbing overseas deals that cut corporate taxes appear to be working, just not entirely the way regulators intended.                  

Chiltern Acquires Pacific Clinical Research

September 29, 2014 10:10 am | News | Comments

Chiltern has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore. The move allows Chiltern to offer integrated services throughout the Asia-Pacific region and strengthens in particular Chiltern's oncology and anti-infective offerings.

Analyst: GSK's $490M Fine to Spark Pharma Strategy Shift in Emerging Markets

September 24, 2014 11:21 am | News | Comments

The scandal and its repercussions will be felt deep into Big Pharma’s operations in emerging markets, causing a fundamental shift in product marketing approaches involving physicians.           

Limits on Overseas Mergers Prompt Renewed Debate

September 23, 2014 8:05 am | by JOSH LEDERMAN, Associated Press; JIM KUHNHENN, Associated Press | News | Comments

The Obama administration's decision to curb the ability of U.S. corporations to skirt taxes by merging with foreign companies kicked off an immediate election-season debate over when and how to tackle the nation's complex corporate tax code.  

China Fines GSK $492M for Bribery

September 19, 2014 5:47 am | by Joe Mcdonald - AP Business Writer - Associated Press | News | Comments

A former executive of drugmaker GlaxoSmithKline and four Chinese co-defendants have been sentenced to prison in a bribery case but may never have to serve that time. China's official Xinhua News Agency said Briton Mark Reilly and his Chinese co-defendants were given a three-year reprieve at their sentencing Friday.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading